A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures (NCT07219407)
An Open-label, Long-term Study Evaluating RAP-219 in Adult Participants With Refractory Onset Seizures
🩺 Plain-English Summary (8th-Grade Level)
This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.
Who can join: Review the eligibility criteria below.
Location: Consultants in Epilepsy and Neurology, PLLC — Boise, Idaho
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Consultants in Epilepsy and Neurology, PLLC — Boise, Idaho
- Mayo Clinic — Rochester, Minnesota
- NYU Langone Comprehensive Epilepsy Center — New York, New York
- Cleveland Clinic Foundation — Cleveland, Ohio
- University of Pennsylvania - Department of Neurology — Philadelphia, Pennsylvania
- Vanderbilt University Medical Center — Nashville, Tennessee
- Baylor College of Medicine — Houston, Texas
📞 Contact the Study Coordinator
Phone: (857) 323-9048
Email: dmoreno@rapportrx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Focal Epilepsy
- Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Peoria, Arizona
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Birmingham, Alabama
- Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures — Miami, Florida
- Breathing Rescue for SUDEP Prevention — Houston, Texas
- Study of Transcranial Direct Current Stimulation to Treat Epilepsy — Rochester, Minnesota
Explore by condition: All Focal Epilepsy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.